Endocrinology Research and Practice
Case Report

Bilateral Atypical Femur Fracture in a Patient Under Bisphosphonate Treatment

1.

Fatih Sultan Mehmet Education and Training Hospital, İstanbul, Turkey

Endocrinol Res Pract 2019; 23: 187-190
DOI: 10.25179/tjem.2018-64415
Read: 2303 Downloads: 611 Published: 01 September 2019

ABSTRACT

Osteoporosis is a systemic skeletal disease that affects most of the elderly people. Bisphosphonate is an effective anti-resorptive drug widely used for the prevention and treatment of osteoporosis. However, recent evidence has linked longterm bisphosphonate use with an atypical fracture. We report a case of a 79-year-old woman who had been on bisphosphonate treatment for eight years and presented with bilateral femur diaphyseal fractures occurring within an interval of a few months. The physicians must consider the possibility of atypical fractures with the fresh onset of groin or mid-thigh pain in patients who have been on bisphosphonate therapy, particularly for more than five years.

 

 

Files
EISSN 2822-6135